Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
NeoFuse
print preview
bookmark
share with colleague
General Information
Company
Mesoblast Ltd.
Description
Allogeneic cell therapy of mesenchymal precursor cells (MPCs) derived from adult bone marrow cells
Molecular Target
Mechanism of Action
Cell therapy
Latest Stage of Development
Phase II
Indication
Bone repair
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy